Pharma Nachrichten

Zeit	Aktuelle Nachrichten Sprache: Alle DE EN	Leser	Medien
05:30	Silence Therapeutics prices $175M public offering at $13.50 per ADS	1	Investing.com
05:24	Silence Therapeutics plc: Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering	144	Business Wire	Silence Therapeutics plc ("Silence" or the "Company"), a global clinical-stage biotechnology company developing novel short interfering RNA ("siRNA") therapies, today announced that it has priced... ► Artikel lesen
04:53	Ihre wichtigsten Termine: Tui, Bechtle, Jenoptik, Douglas, Eon und Freenet mit frischen Zahlen-Updates	384	wallstreetONLINE	© Foto: Clara Margais/dpa/dpa-tmnGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen
04:26	CIPHER PHARMACEUTICALS INC Profit Retreats In Q2	2	RTTNews
04:14	MMJ International Holdings: Dr. Oz's Push to Expand Medicare CBD Access After European Regulators Could Not Establish Safety of Charlotte's Web Hemp Extract	268	ACCESS Newswire	"Medicare patients should not become the testing ground for cannabinoid products that have not undergone the rigorous FDA drug development process required to establish safety, efficacy, manufacturing... ► Artikel lesen
03:42	Vir Biotechnology: Astellas Deal Pushes Cash Above $1 Billion And Extends Runway Into Second Half Of 2028	2	pulse2.com
02:18	Aurora Cannabis Inc (3): Aurora Cannabis confirms receipt of Curaleaf bid	3	Stockwatch
02:02	AVECHO BIOTECHNOLOGY LIMITED: Small Holding Share Sale Facility Completion	1	ASX
01:35	ISLAND PHARMACEUTICALS LIMITED: Cleansing Notice	1	ASX
01:32	ISLAND PHARMACEUTICALS LIMITED: Application for quotation of securities - ILA	1	ASX
00:48	Organigram Global Inc.: Organigram meldet Rekordergebnisse für das dritte Quartal des Geschäftsjahres 2026	333	Business Wire	Quartalsumsatz und bereinigtes EBITDA auf Rekordniveau(1) getrieben durch die Übernahme der Sanity Group Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (das "Unternehmen" oder "Organigram"),... ► Artikel lesen
00:18	If You Invested $1000 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today	2	Benzinga.com
00:18	Pharmather Holdings Ltd: Pharmather launches Personaliz3D business model	1	Stockwatch
00:16	PERCHERON THERAPEUTICS LIMITED: Notice of date of AGM and other relevant dates	-	ASX
00:06	Aurora Cannabis Inc (3): Curaleaf intends to offer to acquire Aurora Cannabis	4	Stockwatch
00:06	Curaleaf Holdings Inc (2): Curaleaf intends to offer to acquire Aurora Cannabis	2	Stockwatch
00:06	CHINARES PHARMA (03320): DATE OF BOARD MEETING	1	HKEx
Di	Pfizer Just Raised Its 2026 Guidance -- but the Boost Leans Heavily on a Drug Running Out the Patent Clock	3	The Motley Fool
Di	Cipher Pharmaceuticals Reports Second Quarter 2026 Results	1	CNW
Di	Savara Inc - S-8, Securities to be offered to employees in employee benefit plans	1	SEC Filings

Zeit

Aktuelle Nachrichten

Sprache: Alle DE EN

Leser

Medien

05:30

Silence Therapeutics prices $175M public offering at $13.50 per ADS

Investing.com

05:24

Silence Therapeutics plc: Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering

144

Business Wire

Silence Therapeutics plc ("Silence" or the "Company"), a global clinical-stage biotechnology company developing novel short interfering RNA ("siRNA") therapies, today announced that it has priced...
► Artikel lesen

04:53

Ihre wichtigsten Termine: Tui, Bechtle, Jenoptik, Douglas, Eon und Freenet mit frischen Zahlen-Updates

384

wallstreetONLINE

© Foto: Clara Margais/dpa/dpa-tmnGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine...
► Artikel lesen

04:26

CIPHER PHARMACEUTICALS INC Profit Retreats In Q2

RTTNews

04:14

MMJ International Holdings: Dr. Oz's Push to Expand Medicare CBD Access After European Regulators Could Not Establish Safety of Charlotte's Web Hemp Extract

268

ACCESS Newswire

"Medicare patients should not become the testing ground for cannabinoid products that have not undergone the rigorous FDA drug development process required to establish safety, efficacy, manufacturing...
► Artikel lesen